GlassScriptPhysician profile
Monica Rivera
NPI 1245626126
$2,195.57
in general payments reported to CMS, 2019-2025
22 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.97 · 2022: $749 · 2023: $400 · 2024: $553 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $473.04 | 2022-2023 | |
| Allergan, INC. | $229.21 | 2022 | |
| Daiichi Sankyo INC. | $179.39 | 2024-2025 | Enhertu, Vanflyta |
| Revance Therapeutics, INC. | $137.64 | 2024 | Daxxify |
| Incyte Corporation | $129.60 | 2023 | Pemazyre |
| E.R. Squibb & Sons, L.L.C. | $124.48 | 2025 | Opdivo |
| Taiho Oncology, INC. | $119.20 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.22 | 2024-2025 | |
| Abbvie INC. | $105.63 | 2021-2025 | |
| Lilly USA, LLC | $94.67 | 2022 | |
| Sobi, INC | $68.48 | 2023-2025 | |
| Deciphera Pharmaceuticals INC. | $66.60 | 2023-2024 | Qinlock |
| Genentech USA, INC. | $66.55 | 2023-2024 | Xolair |
| Genzyme Corporation | $65.72 | 2025 | |
| Mirati Therapeutics, INC. | $42.70 | 2023-2024 | Krazati |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $35.00 | 2025 | Auvelity |
| Acrotech Biopharma INC. | $29.86 | 2025 | Beleodaq |
| Sanofi-Aventis U.S. LLC | $26.45 | 2022 | |
| Pfizer INC. | $23.48 | 2022 | |
| Merck Sharp & Dohme LLC | $23.36 | 2022 | |
| Janssen Biotech, INC. | $20.92 | 2022 | |
| La Jolla Pharmaceutical Company | $20.37 | 2025 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.